Sagittarius Life Science (ROCO:3205) OCF Margin %: -53.75% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:3205 Sagittarius Life Science Corp ROCO:3205
47 GF Score
Price NT$50.20
GF Value NT$17.93
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Sagittarius Life Science OCF Margin %?

Sagittarius Life Science ROCO:3205 -1.38% 47 OCF Margin % is -53.75% as of Dec. 2025. GuruFocus rates ROCO:3205 with a GF Score™ of 47/100 and a GF Value™ of NT$17.93 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 950 Biotechnology companies, Sagittarius Life Science ranks better than 61.89% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Sagittarius Life Science's Cash Flow from Operations for the three months ended in Dec. 2025 was NT$-21.3 Mil. Sagittarius Life Science's Revenue for the three months ended in Dec. 2025 was NT$39.6 Mil. Therefore, Sagittarius Life Science's OCF Margin % for the quarter that ended in Dec. 2025 was -53.75%.

As of today, Sagittarius Life Science's current OCF Yield % is -1.02%.

The historical rank and industry rank for Sagittarius Life Science's OCF Margin % or its related term are showing as below:

ROCO:3205' s OCF Margin % Range Over the Past 10 Years
Min: -23.82   Med: -10.21   Max: 26.03
Current: -10.42

During the past 13 years, the highest OCF Margin % of Sagittarius Life Science was 26.03%. The lowest was -23.82%. And the median was -10.21%.

ROCO:3205's OCF Margin % is ranked better than
61.89% of 950 companies
in the Biotechnology industry
Industry Median: -64.565 vs ROCO:3205: -10.42

Sagittarius Life Science OCF Margin % Related Terms

Sagittarius Life Science OCF Margin % Historical Data

* Premium members only.

The historical data trend for Sagittarius Life Science's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sagittarius Life Science OCF Margin % Chart

Sagittarius Life Science Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.97 -10.00 -15.75 -9.51 -10.42

Sagittarius Life Science Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.93 -7.34 -6.65 0.13 -53.75

ROCO:3205 vs VRTX, REGN, ALNY: OCF Margin % Comparison

For the Biotechnology subindustry, Sagittarius Life Science's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sagittarius Life Science OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sagittarius Life Science's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Sagittarius Life Science's OCF Margin % falls into.


ROCO:3205
47GF Score
Sagittarius Life Science Corp ROCO:3205
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sagittarius Life Science OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Sagittarius Life Science's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-36.046/346.08
=-10.42 %

Sagittarius Life Science's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-21.266/39.567
=-53.75 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -53.75% mean?
Sagittarius Life Science (ROCO:3205) has a OCF Margin % of -53.75% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Sagittarius Life Science and its competitors. According to the industry distribution chart, Sagittarius Life Science ranks #362 out of 950 companies in the Biotechnology industry, placing it in the top 38.1%.
Is Sagittarius Life Science's OCF Margin % too high?
Sagittarius Life Science's current OCF Margin % is -53.75%. Based on the distribution chart, Sagittarius Life Science ranks #362 out of 950 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Sagittarius Life Science has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sagittarius Life Science's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Sagittarius Life Science ranks #362 out of 950 companies for OCF Margin %. This puts Sagittarius Life Science in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Sagittarius Life Science and its competitors. Sagittarius Life Science's current OCF Margin % is -53.75%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sagittarius Life Science stock overvalued right now?
Based on GuruFocus' analysis, Sagittarius Life Science (ROCO:3205) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$17.93, compared to a current price of NT$50.20 — trading 180% above its estimated fair value. The current OCF Margin % is -53.75%. Sagittarius Life Science's overall GF Score™ is 47/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Sagittarius Life Science (ROCO:3205), the current OCF Margin % is -53.75% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sagittarius Life Science (ROCO:3205) Overvalued in 2026?

Based on GuruFocus' analysis, Sagittarius Life Science stock appears to be overvalued. The current stock price of NT$50.20 is trading 180% above its estimated GF Value™ of NT$17.93. GuruFocus considers Sagittarius Life Science to be Significantly Overvalued.

Key valuation signals for ROCO:3205:

  • OCF Margin %: -53.75%
  • GF Value™: NT$17.93 vs. price of NT$50.20 (180% above fair value)
  • GF Score™: 47/100 with 6 warning signs

No single metric tells the full story. See the ROCO:3205 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sagittarius Life Science Business Description

Address No. 3, Park Street, 10-6th Floor, Nangang District, Taipei, TWN
Sagittarius Life Science Corp is a Taiwan-based company engaged in the biotechnology and pharmaceutical sectors. The segment includes: Food and Others, with the majority of revenue from Food.
47GF Score

Get the complete analysis for ROCO:3205

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$50.20
Price
NT$17.93
GF Value